You can now review and comment on this draft guideline which will partially update Advanced breast cancer: diagnosis and treatment (CG81) and Early and locally advanced breast cancer: diagnosis and management (NG101).
The consultation closes on Monday 23rd September 2024 at 5pm
How to comment
1. Register your organisation or comment as an individual
If you’re commenting for an organisation, your organisation needs to be registered as a stakeholder.
Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your comments to them.
We can accept comments from individuals. These will be considered, but you won’t get a formal response and they won’t be posted on the NICE website. Wherever possible we encourage you to submit your comments through a registered stakeholder organisation.
2. Read the consultation documents
Documents to comment on:
- Draft guideline
- Evidence review O
- Evidence review P
- Equality and health inequalities assessment
- Supporting information: Methods
- Supporting information: Acknowledgements
Other information about the consultation
- Committee member list
- Declaration of interests register
- Final scope – for information
3. Add your comments
- You must use this form.
- You must declare any links with, or funding from, the tobacco industry
If you share similar views with another organisation, send a joint response.
Make sure you consider:
- The areas that will have the biggest impact on practice and be challenging to implement
- How to help users overcome challenges
Developing NICE guidelines: how to get involved suggests some other areas to comment on.
4. Email the form to us
Email: breastcancerupdate@nice.org.uk
Deadline: Monday 23rd September 2024 at 5pm